Tag: Libtayo
Sanofi: Libtayo rights transferred to Regeneron
Read also (CercleFinance.com) – Sanofi announced on Thursday that it had sold its American partner Regeneron the exclusive licensing rights to the cancer drug Libtayo on a global scale. Under…
Sanofi sells Libtayo licensing rights to Regeneron for $900m
PARIS (Agefi-Dow Jones)–The pharmaceutical group Sanofi announced Thursday that it has sold its American partner Regeneron the exclusive licensing rights to Libtayo worldwide, for an initial amount of 900 million…
Sanofi: Libtayo rights sold to Regeneron
Sanofi announced Thursday that it has ceded its American partner Regeneron the exclusive licensing rights to the cancer drug Libtayo on a global scale. Under the terms of the agreement,…
Sanofi and Regeneron withdraw license application for Libtayo in the United States
Sanofi and Regeneron withdraw license application for Libtayo in the United States | Photo credits: (c) Sanofi Pasteur PARIS (Agefi-Dow Jones)–The pharmaceutical group Sanofi and the biotechnology company Regeneron announced…